๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University201 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School89 Nanjing First Hospital, Nanjing Medical University68 The Second Hospital of Nanjing Medical University32 Nanjing Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Nanjing

1193 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
NCT07382375Aortic Aneurysm and Dissection
Nanjing Medical University
Not applicable
300
Beijing, Changzhou, Chengdu, Fuzhou, Guangzhou, Nanchang, Nanjing, Shanghai
2027-12-31
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Beijing, Chongqing, Guangzhou, Guiyang, Harbin, Wuhan, Changsha, Nanjing
2027-11-23
Not yet open
Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
NCT07700524Coronary Artery Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
190
Nanjing
2027-01-01
Not yet open
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
NCT07349979Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease, Stable GDMT
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,154
Nanjing
2026-12-30
Not yet open
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction
NCT07331220Heart Failure With Preserved Ejection Fraction
Nanjing First Hospital, Nanjing Medical University
Not applicable
310
Nanjing
2026-12-30
Not yet open
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
NCT06136507Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
NCT07789015Idiopathic Inflammatory Myopathies
Boehringer Ingelheim
Phase 3
270
Beijing, Chongqing, Dongguan, Guangzhou, Hefei, Luoyang, Nanchang, Nanjing
2026-11-09
Not yet open
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
NCT07796477T2DM (Type 2 Diabetes Mellitus)
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2
240
Nanjing
2026-11-06
Not yet open
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484Heart Failure Due to Coronary Artery Disease
Shanghai Zhongshan Hospital
Phase 3
1,526
Hefei, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Nanjing, Dalian, Xi'an
2026-11-01
Not yet open
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07763938Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University
Phase 1
80
Nanjing
2026-11-01
Not yet open
AI Assistance for Detecting Active Bleeding During DSA Procedures
NCT07824739DSA, Bleeding, AI (Artificial Intelligence), Hemorrhage
Zhongda Hospital
Not applicable
1,324
Nanjing
2026-10-01
Not yet open
Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy
NCT07789184Gastric Cancer, Peritoneal Metastasis
Hua Huang, MD, PhD
Phase 3
170
Beijing, Chongqing, Zhangzhou, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang
2026-10-01
Not yet open
SNC116 Therapy for Refractory Systemic Lupus Erythematosus
NCT07748156Systemic Lupus Erythematosus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase EARLY_PHASE1
28
Nanjing
2026-10
Not yet open
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anfluยฎ) Pregnant Women (AnFLU-PREG)
NCT07832201Influenza
Sinovac Biotech Co., Ltd
Phase 4
150
Changsha, Chengdu, Chongqing, Guangzhou, Nanjing, Wuhan
2026-10
Not yet open
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
NCT07377981Dexmedetomidine, Ketamine, Analgesia, Respiratory Therapy
The First Affiliated Hospital with Nanjing Medical University
Phase 4
356
Nanjing
2026-09-28
Not yet open
Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
NCT07796191Healthy Adult Participants
Jiangsu vcare pharmaceutical technology co., LTD
Phase 1
84
Nanjing
2026-09-20
Not yet open
A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies
NCT07628582Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University
Phase 1
48
Nanjing
2026-09-15
Not yet open
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
NCT07540988Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
466
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou
2026-09-14
Not yet open
A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)
NCT07767188Lupus Nephritis
Zhao Minghui
Phase 3
70
Fuzhou, Guangzhou, Harbin, Nanjing, Xuzhou, Nanchang, Shenyang, Yantai
2026-09-10
Not yet open
A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
NCT07782086Breast Cancer
Shuangyue Liu
Not applicable
30
Hefei, Beijing, Nanjing, Xuzhou, Dalian, Shanghai, Xiโ€™an, Chengdu
2026-09-07
Not yet open
Sphere-9 PAF China Study
NCT07789925Paroxysmal Atrial Fibrillation (PAF)
Medtronic Cardiac Ablation Solutions
Not applicable
180
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang, Tianjin
2026-09-02
Not yet open
Diagnostic Accuracy of A Diquat Quantitative Detection Kit and A Portable Mass Spectrometry System for Quantifying Diquat Concentrations in Human Blood Samples
NCT07399574Diquat Poisoning
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
60
Nanjing
2026-09-01
Not yet open
Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal Surgery
NCT07783464Postoperative Delirium (POD), Heart Rate Variability (HRV)
The First Affiliated Hospital with Nanjing Medical University
Observational
500
Nanjing
2026-09-01
Not yet open
Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL
NCT07831395Richter Syndrome
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
23
Zhengzhou, Changsha, Nanchang, Guangzhou, Nanjing, Wuhan
2026-09-01
Not yet open
Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.
NCT07803991Overweight or Obesity
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2
360
Nanjing
2026-09-01
Not yet open
Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026)
NCT07824765Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Observational
2,658
Nanjing
2026-09-01
Recruiting
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
NCT07764094PCI, Drug-coated Balloon, Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Observational
500
Chuzhou, Tongling, Huai'an, Lianyungang, Nanjing, Xuzhou, Yixing
2026-09-01
Not yet open
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal
Eli Lilly and Company
Phase 3
2,001
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
2026-09
Not yet open
ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR
NCT07799649Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Observational
150
Nanjing
2026-09
Not yet open
Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short Stature
NCT07815626Idiopathic Short Stature (ISS)
Zhongshan Sansure Hygene Biomedicine Co., Ltd.
Phase 3
240
Hefei, Beijing, Xiamen, Guangzhou, Tangshan, Wuhan, Changsha, Nanjing
2026-09
Not yet open
ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular
NCT07813572Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
600
Nanjing
2026-09
Not yet open
Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy
NCT07803965Acute Pancreatitis
Beijing Sungen Biomedical Technology Co., Ltd
Phase 2
129
Chengdu, Guizhou, Hangzhou, Hefei, Luoyang, Nanchang, Nanjing, Ningbo
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Recruiting
This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
NCT07649122Prostate Cancer
Norroy Bioscience Co., LTD
Phase 3
232
Nanjing, Wuxi
2026-08-31
Not yet open
A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07707167LA HNSCC
Jiangsu Cancer Institute & Hospital
Phase 2
35
Nanjing
2026-08-31
Not yet open
Pirtobrutinib+Sonrotoclax๏ผˆPS) Regimen in the Treatment of B-Cell Lymphoma
NCT07744750DLBCL - Diffuse Large B Cell Lymphoma, Richter Transformation, CLL / SLL, MZL
Changzhou No.2 People's Hospital
Phase 2
40
Nanjing
2026-08-30
Recruiting
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
NCT07704047Short Bowel Syndrome, SBS
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 2
8
Nanjing
2026-08-30
Recruiting
A Study of BGM0504 in Early T2DM With Obesity
NCT07743983Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
372
Nanjing
2026-08-30
Not yet open
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
NCT07745257HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
Sun Yat-sen University
Phase 2
40
Guangzhou, Shijiazhuang, Anyang, Zhengzhou, Nanjing, Nanchang, Dalian, Chengdu
2026-08-28
Recruiting
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
NCT07576660Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Phase 3
1,704
Nanjing
2026-08-27
Recruiting
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
NCT07747857Type 2 Diabetes Mellitus Combined With Overweight or Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
72
Fuzhou, Guangzhou, Langfang, Luoyang, Wuhan, Yichang, Changsha, Nanjing
2026-08-25
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
NCT07779252Moderate to Severe Glabellar Lines
Ipsen
Phase 3
160
Guangzhou, Changsha, Nanjing, Wuxi, Jingโ€™an, Chengdu, Hangzhou, Beijing
2026-08-25
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
500
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
2026-08-24
Recruiting
Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVร‰DERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adults
NCT07794878Nasolabial Folds
AbbVie
Phase 3
288
Beijing, Guangzhou, Shenzhen, Nanjing, Xianyang
2026-08-19
Recruiting
Clinical Study of HRS-2129 for Acute Gouty Arthritis
NCT07706777Acute Gouty Arthritis
Shandong Suncadia Medicine Co., Ltd.
Phase 2
90
Guangzhou, Nanjing
2026-08-19
Not yet open
Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction
NCT07800819Gastric Adenocarcinoma, Adenocarcinoma of the Esophagogastric Junction
The First Affiliated Hospital with Nanjing Medical University
Observational
250
Nanjing
2026-08-15
Not yet open
HMPL-A830 in Solid Tumors
NCT07718581Solid Tumor, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Nanjing, Taiyuan
2026-08-15
Not yet open
A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
NCT07741617Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
54
Nanjing
2026-08-15
Recruiting
A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced Malignancies
NCT07810933ALK Positive Advanced Malignancies
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2
330
Guangzhou, Nanjing
2026-08-12
Active, closed
A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants
NCT07681479Fluid Retention Due to Heart Failure
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
6
Nanjing
2026-08-11
Recruiting
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
NCT07615101Prostate Cancer (Diagnosis)
Norroy Bioscience Co., LTD
Phase 3
365
Nanjing, Wuxi
2026-08-06
Recruiting
ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase
NCT07751536Leptomeningeal Metastasis From Lung Cancer
Shuanghu Yuan
Not applicable
84
Hefei, Nanjing
2026-08-05
Recruiting
A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy
NCT07468851High-risk Non-muscle-invasive Bladder Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2
180
Beijing, Nanjing
2026-08-05
Recruiting
Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
NCT07745881Nerve Block, Thoracoscopic Radical Resection of Lung Cancer
Nanjing First Hospital, Nanjing Medical University
Not applicable
130
Nanjing
2026-08-05
Recruiting
A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.
NCT07743944Breast Cancer
AstraZeneca
Observational
2,000
Nanjing
2026-08-05
Not yet open
Epidural Spinal Cord Stimulation for Respiratory Recovery in Brain Injury
NCT07766681Brain Injuries, Respiratory Failure
Zhongda Hospital
Not applicable
10
Beijing, Nanjing, Suzhu
2026-08-05
Recruiting
Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
NCT07621367Chronic Ischemic-Hypoxic Enteropathy
The Second Hospital of Nanjing Medical University
Not applicable
100
Nanjing
2026-08-02
Recruiting
Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial
NCT07731828Cervical Neoplasms
The First Affiliated Hospital with Nanjing Medical University
Phase 2
35
Nanjing
2026-08-01
Not yet open
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
156
Beijing, Chongqing, Lanzhou, Baoding, Zhengzhou, Nanjing, Changchun, Jinan
2026-08-01
Not yet open
Diagnostic Performance of a Flexible Penile Monitoring System for ED
NCT07762469Erectile Dysfunction
Bin Xu
Observational
60
Nanjing
2026-08-01
Not yet open
Yanlishuang Buccal Dropping Pills for Acute Pharyngitis
NCT07761013Acute Pharyngitis
Beijing University of Chinese Medicine
Not applicable
400
Guangzhou, Guiyang, Harbin, Nanjing, Nanchang, Jinan, Shanghai, Chengdu
2026-08-01
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
NCT07619989Obesity & Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
24
Nanjing
2026-08-01
Not yet open
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
NCT07612670Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Liver Cirrhosis
The First Affiliated Hospital with Nanjing Medical University
Observational
700
Nanjing
2026-08-01
Not yet open
The Efficacy of CAPCT in Patients With PTCL
NCT07746245Peripheral T-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
58
Nanjing
2026-08-01
Recruiting
Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients
NCT07519512Mechanical Ventilator Care
Southeast University, China
Not applicable
1,600
Nanjing
2026-08-01
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524Primary Light Chain (AL) Amyloidosis
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
32
Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2026-08
Not yet open
Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application
NCT07781956Non-Muscle-Invasive Bladder Cancer (NMIBC)
Nanjing First Hospital, Nanjing Medical University
Not applicable
40
Nanjing
2026-08
Not yet open
A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT07753369Small Lymphocytic Lymppho, Relapsed/Refractory Chronic Lymphocytic Leukemia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
128
Zhengzhou, Nanjing
2026-08
Not yet open
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
NCT07765537Primary Membranous Nephropathy
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
55
Hefei, Beijing, Guangzhou, Shenzhen, Wuhan, Changsha, Nanjing, Chengdu
2026-08
Not yet open
R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
NCT07764601Primary Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma
WEI XU
Not applicable
58
Changzhou, Huai'an, Nanjing, Wuxi, Yixing
2026-08
Not yet open
Diagnostic Accuracy and Safety of the Attention-Deficit/Hyperactivity Disorder Auxiliary Evaluation System (AHEF) in Chinese Children Aged 6 to 12
NCT07683156Attention-Deficit, Hyperactivity Disorder
Chongqing Jinsaixing Medical Technology Co., Ltd
Observational
570
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Changchun, Shanghai, Chengdu
2026-07-31
Recruiting
Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms
NCT07764081Coronary Artery Disease, Aneurysms, Coronary Intervention
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Nanjing
2026-07-31
Not yet open
Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
NCT07744724DLBCL - Diffuse Large B Cell Lymphoma, Pirtobrutinib
Changzhou No.2 People's Hospital
Phase 2
48
Nanjing
2026-07-31
Not yet open
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
NCT07744737DLBCL - Diffuse Large B Cell Lymphoma, R-CHOP Chemotherapy, Pirtobrutinib
Changzhou No.2 People's Hospital
Phase 2
34
Nanjing
2026-07-30
Recruiting
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
NCT07533708mCRPC or Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
48
Nanchang, Naning, Nanjing, Shanghai, Xiamen
2026-07-30
Not yet open
A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases
NCT07731685Pain in Bone Metastases
Jiangsu vcare pharmaceutical technology co., LTD
Phase 1
26
Nanjing
2026-07-30
Not yet open
The COMBINE-AF Trial
NCT07633509Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation
Yunlong Wang
Not applicable
430
Beijing, Nanjing
2026-07-27
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
NCT07670884Chronic Management of Body Weight
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
675
Zhengzhou, Nanjing
2026-07-24
Recruiting
Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis
NCT07795723Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
454
Nanjing
2026-07-20
Recruiting
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
NCT07767370Diarrhea Chronic, UC - Ulcerative Colitis
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
36
Nanjing
2026-07-20
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Not yet open
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
Chengdu SciMount Pharmatech Co., Ltd.
Phase 2
60
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Nanjing
2026-07-16
Not yet open
Neoadjuvant SHR-A1811 and SHR-A1701 ยฑ Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
NCT07716111Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
24
Nanjing
2026-07-16
Recruiting
Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naรฏve Mantle Cell Lymphoma (MCL)
NCT07719556Mantle Cell Lymphoma (MCL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
39
Changzhou, Nanjing
2026-07-15
Recruiting
A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
NCT07609823Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
75
Nanjing
2026-07-14
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
NCT07664553Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
600
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang
2026-07-08
Recruiting
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
NCT07662213Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
1,200
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang
2026-07-06
Not yet open
Dynamic Multimodal Delirium Warning After Cardiac Surgery
NCT07686900Postoperative Delirium, Cardiac Surgical Procedures
Southeast University, China
Observational
200
Nanjing
2026-07-06
Recruiting
Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students
NCT07625969Obesity, Food Selection
Nanjing Medical University
Not applicable
1,000
Nanjing
2026-07-02
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Recruiting
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
NCT07711314Prostate Cancer (Post Prostatectomy)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
48
Nanjing
2026-07-01
Not yet open
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
NCT07668323Medium Vessel Occlusion, Ischemic Stroke, Acute
The First Affiliated Hospital with Nanjing Medical University
Phase 3
306
Nanjing
2026-07-01
Not yet open
Vascular Aging and Acute Kidney Injury After Cardiac Surgery
NCT07727772Acute Kidney Injury Cardiac Surgery, Postoperative Complications, Vascular Aging
Nanjing First Hospital, Nanjing Medical University
Observational
472
Nanjing
2026-07-01
Not yet open
Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosis
NCT07723053Adolescent Idiopathic Scoliosis, Lenke Type 1 Adolescent Idiopathic Scoliosis, Lenke Type 5 Adolescent Idiopathic Scoliosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
300
Nanjing
2026-07-01
Not yet open
A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy
NCT07669740Gastric Cancer (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
30
Nanjing
2026-07-01
Not yet open
Early Electroacupuncture for Post-TURP LUTS
NCT07736807Benign Prostatic Hyperplasia
Zhongda Hospital
Not applicable
144
Nanjing
2026-07-01
Not yet open
Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis
NCT07706998Learning
Nanjing University
Not applicable
50
Nanjing
2026-07-01
Recruiting
A Study of Metformin to Improve Cardiac Function After LVAD Implantation
NCT07666698Heart Failure, Left Ventricular Assist Device
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
108
Nanjing, Hangzhou, Haโ€™erbin, Huai'an, Zhengzhou
2026-07-01
Not yet open
Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07628595Multiple Myeloma (MM)
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
19
Nanjing
2026-07-01
Not yet open
177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial
NCT07677566Prostate Cancer, Prostate Cancer Patients
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4
20
Nanjing
2026-07-01
Rows per page Showing 1–100 of 1193
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,193 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

713 of the 1,193 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 232 have not yet opened recruitment, 216 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanjing), 1,193 studies
PhaseStudiesRecruitingShare
Not applicable26115621.9%
Phase 223715119.9%
Observational22914219.2%
Phase 321810918.3%
Phase 174516.2%
Phase 1/272506%
Phase 450244.2%
Phase EARLY_PHASE129152.4%
Phase 2/323151.9%

Most active sponsors

Lead sponsors with the most studies (Nanjing)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital with Nanjing Medical University201130
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School8957
Nanjing First Hospital, Nanjing Medical University6841
The Second Hospital of Nanjing Medical University3221
Nanjing Medical University3016
AstraZeneca2819
Zhongda Hospital2816
Jinling Hospital, China2622
Novartis Pharmaceuticals259
Southeast University, China1913
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.